TriSalus Life Sciences Warrant
TLSIW
30 hedge funds and large institutions have $5.36M invested in TriSalus Life Sciences Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
20% more funds holding
Funds holding: 25 → 30 (+5)
7% less capital invested
Capital invested by funds: $5.77M → $5.36M (-$405K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GL
Governors Lane
New York
|
+$230K |
| 2 |
KC
Kepos Capital
New York
|
+$133K |
| 3 |
Walleye Capital
New York
|
+$96.6K |
| 4 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
+$66K |
| 5 |
HF
HRT Financial
New York
|
+$11.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$123K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$56K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$32K |
| 4 |
BlackRock
New York
|
-$6.44K |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.41K |
TLSIW Hedge Fund Activity: Q4 2021 in Review
30 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2021, worth a combined $5.36M — down 7% from $5.77M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TLSIW positions and 3 closed out — a net gain of 5 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Governors Lane, opening a new position worth an estimated $230K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $123K sold.
- 30 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2021, up from 25 in Q3 2021.
- Funds reported $5.36M of TriSalus Life Sciences Warrant stock for Q4 2021, down 7% quarter-over-quarter.
- 8 funds opened new TriSalus Life Sciences Warrant positions in Q4 2021 and 3 closed out, a net change of +5 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q4 2021 was Governors Lane, an estimated $230K added.
- The largest TriSalus Life Sciences Warrant seller in Q4 2021 was Polar Asset Management Partners, an estimated $123K sold.
Based on aggregated 13F filings for Q4 2021.